The reviewed recommendations have been published in the Journal of Clinical Endocrinology & Metabolism and include guidelines on glucocorticoid use among others.
Large Scale Analysis Examines Effect on Smoking on Outcomes of Primary PCI in Patients with STEMI
In a recent large-scale individual patient-data pooled analysis, smoking was unrelelated to microvascular obstructions or infarct size, but was associated with worse prognosis after primary PCI in STEMI. According the researchers: "The smoker’s paradox may be explained by the younger age and fewer cardiovascular risk factors in smokers compared with nonsmokers."
CDC Publishes Stats Surrounding Total and High-Density Lipoprotein Cholesterol Adults from 2015-2018
In mid-April, the Centers for Disease Control and Prevention (CDC) published updated findings regarding the total and high-density lipoprotein cholesterol in adults from 2015-2018. The results demonstrated that during this period 11.4% of adults had total cholesterol--with prevalence similar by race and Hispanic origin., and with rates highest among adults aged 40-59.
AHA Releases Scientific Statement Regarding Clinical Management of of Stable Coronary Artery Disease in T2DM Patients
The American Heart Association has recently published a scientific statementdiscussing the role that T2DM has in the selection of testing for CAD, in medical management, and in the selection of revascularization strategy. Additionally the scientific statement
addresses the role of glycemic management (both in intensity of control and choice of medications) in cardiovascular outcomes.
U.S. Preventive Services Task Force Publishes Statement on High Blood Pressure Screening in Children and Adolescents
Congratulations to Dr. Keith C. Ferdinand for being appointed by Louisiana Governor John Bel Edwards to the COVID-19 Health Equity Task Force Medical Subcommmittee.
WEBINAR SPOTLIGHT
Join Drs. Gregory Poland, Michael Ison, and Stefan Gravenstein as they address the latest evidence in influenza treatment and management of patients with chronic cardiometabolic health conditions.
CMHC chair Anne Peters, MD, discusses the role of CGM in optimizing glucose control, exercise and nutrition in diabetes patients undergoing cardiopulmonary rehabilitation
In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice. (Recorded April 1, 2020)
Amid the COVID-19 pandemic, clinicians must continue to diagnose, assess, and treat patients for both COVID-19 and non-COVID-19 medical issues. This extremely contagious disease has brought upon new realities and posed significant challenges to the healthcare system and the practice of medicine. To this end, CMHC conducted a survey of cardiometabolic clinicians to gauge the impact of COVID-19 on their practices as well as the sources they rely upon to keep themselves updated regarding COVID-19.
